SG Americas Securities
SMMT icon

SG Americas Securities’s Summit Therapeutics SMMT Stock Holding History

SG Americas Securities’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
53,523
+37,934
+243% +$613K ﹤0.01% 1751
2025
Q4 		$273K Buy
15,589
+10,472
+205% +$197K ﹤0.01% 2798
2025
Q3 		$106K Buy
+5,117
New +$124K ﹤0.01% 3059
2025
Q1 		– Sell
-13,169
Closed -$235K – 3744
2024
Q4 		$235K Sell
13,169
-19,587
-60% -$380K ﹤0.01% 2008
2024
Q3 		$717K Buy
+32,756
New +$458K ﹤0.01% 1364
2022
Q1 		– Sell
-12,671
Closed -$34K – 3391
2021
Q4 		$34K Sell
12,671
-10,529
-45% -$50.6K ﹤0.01% 3226
2021
Q3 		$116K Buy
+23,200
New +$166K ﹤0.01% 3594

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return